Your session is about to expire
← Back to Search
New Thyroid Medication for Hypothyroidism
Study Summary
This trial studies a new type of thyroid medication to determine a target dose conversion factor and assess its safety and tolerability in people with hypothyroidism.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am 18-65 years old, have chronic hypothyroidism, and have been on a stable dose of levothyroxine for at least 3 months.My daily dose of levothyroxine is either less than 50 μg or more than 375 μg.I am not using any thyroid treatments other than those provided in the study.Your thyroid hormone levels are normal.Your thyroid hormone levels must be normal when tested at the central laboratory and at least 3 months before the screening.You are allergic to levothyroxine in any form.I am taking more than 2 micrograms per kilogram of my body weight of levothyroxine daily.
Frequently Asked Questions
Is this experiment currently recruiting participants?
"According to the latest data hosted by clinicaltrials.gov, this medical trial is still actively enrolling participants. It was initially published on April 21st 2023 and most recently updated May 4th 2023."
Who is eligible to enroll in this medical trial?
"This clinical trial is looking to enrol 44 individuals that suffer from hypothyroidism, and are aged between 18-65 years old."
Is this research open to individuals younger than seventy years of age?
"The protocol for this study necessitates that candidates are 18 years old or above, while still being under the age of 65."
How is the safety profile of XP-8121 when used by human subjects?
"The safety of XP-8121 was gauged at a 2 since although there is evidence to suggest it safe, efficacy data has yet to be collected."
How many participants have joined this trial thus far?
"Affirmative. According to the details provided on clinicaltrials.gov, this research is ongoing and in need of volunteers; it was first advertised on April 21st 2023 with a last update being made on May 4th 2023 for 44 participants at 3 distinct medical centres."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger